| 产品编号 | CAS号 | 项目名称规格 | 分子式 | 加入购物车 |
|---|---|---|---|---|
| S783511 | 2757083-20-6 | (S)-4-(叔丁基)-2-(5-氯吡啶-2-基)-4,5-二氢恶唑, 97%, 99% e.e. (S)-4-(tert-Butyl)-2-(5-chloropyridin-2-yl)-4,5-dihydrooxazole, 97%, 99% e.e. |
C12H15ClN2O | |
| S873987 | 158257-41-1 | (S)-4-异丙基-2,5-二氧代恶唑烷-3-羧酸苄酯, 97% benzyl (4S)-2,5-dioxo-4-(propan-2-yl)-1,3-oxazolidine-3-carboxylate, 97% |
C14H15NO5 | |
| S785224 | 2757084-59-4 | (S)-4-苄基-2-((R)-1-(二苯基膦基)哌啶-2-基)-4,5-二氢恶唑, 97% (S)-4-Benzyl-2-((R)-1-(diphenylphosphanyl)piperidin-2-yl)-4,5-dihydrooxazole, 97% |
C27H29N2OP | |
| S785240 | 2757084-47-0 | (S)-4-苄基-2-((S)-1-(二苯基膦基)哌啶-2-基)-4,5-二氢恶唑, 97% (S)-4-Benzyl-2-((S)-1-(diphenylphosphanyl)piperidin-2-yl)-4,5-dihydrooxazole, 97% |
C27H29N2OP | |
| S784485 | 2757083-54-6 | (S)-4-苄基-2-(5-氟吡啶-2-基)-4,5-二氢恶唑, 97% (S)-4-Benzyl-2-(5-fluoropyridin-2-yl)-4,5-dihydrooxazole, 97% |
C15H13FN2O | |
| S783659 | 2757083-21-7 | (S)-4-苄基-2-(5-氯吡啶-2-基)-4,5-二氢恶唑, 97% (S)-4-Benzyl-2-(5-chloropyridin-2-yl)-4,5-dihydrooxazole, 97% |
C15H13ClN2O | |
| S784443 | 2757083-28-4 | (S)-4-苄基-2-(5-溴吡啶-2-基)-4,5-二氢恶唑, 97%, 99% e.e. (S)-4-Benzyl-2-(5-bromopyridin-2-yl)-4,5-dihydrooxazole, 97%, 99% e.e. |
C15H13BrN2O | |
| S783536 | 2828438-61-3 | (S)-4-苄基-2-(6-环丙基吡啶-2-基)-4,5-二氢恶唑, 95% (S)-4-Benzyl-2-(6-cyclopropylpyridin-2-yl)-4,5-dihydrooxazole, 95% |
C18H18N2O | |
| S743989 | 1401065-46-0 | (S)-4-苄基-3-(5,5,5-三氟戊酰基)恶唑烷-2-酮, 97% (S)-4-Benzyl-3-(5,5,5-trifluoropentanoyl)oxazolidin-2-one, 97% |
C15H16NO3F3 | |
| S702790 | 2936672-01-2 | (S)-5,6-二氢-4H-二螺[苯并[c]异恶唑-7,1'-环己烷-2',2''-[1,3]二氧戊环]-3-甲酰亚胺, 95% (S)-5,6-Dihydro-4H-dispiro[benzo[c]isoxazole-7,1'-cyclohexane-2',2''-[1,3]dioxolane]-3-carboximidamide, 95% |
C15H21N3O3 | |
| S756455 | 1456891-34-1 | (S)-N2-(苯并[d]恶唑-6-基)-N4-(1-环己基乙基)-N6-乙基-N6-(2-(乙基氨基)乙基)-1,3,5-三嗪环-2,4,6-三胺, 98% (S)-N2-(Benzo[d]oxazol-6-yl)-N4-(1-cyclohexylethyl)-N6-ethyl-N6-(2-(ethylamino)ethyl)-1,3,5-triazine-2,4,6-triamine, 98% |
C24H36N8O | |
| S868349 | 190601-12-8 | (S,S'')-2,2''-双[(S)-4-异丙基恶唑啉-2-基]-1,1''-双二茂铁, ≥98% (S,S'')-2,2''-Bis[(S)-4-isopropyloxazolin-2-yl]-1,1''-biferrocene, ≥98% |
C32H36Fe2N2O2 | |
| S676881 | 126587-36-8 | (S,Z)-tert-Butyl 4-(3-methoxy-3-oxoprop-1-en-1-yl)-2,2-dimethyloxazolidine-3-carboxylate, 95% (S,Z)-tert-Butyl 4-(3-methoxy-3-oxoprop-1-en-1-yl)-2,2-dimethyloxazolidine-3-carboxylate, 95% |
C14H23NO5 | |
| S703272 | 1586000-47-6 | (SP-4-1)-[1,3-双[2,6-双(1-甲基乙基)苯基]-1,3-二氢-2H-咪唑-2-亚基]二氯(4,5-二氢-2-苯基恶唑-κN3)钯, 95% (SP-4-1)-[1,3-Bis[2,6-bis(1-methylethyl)phenyl]-1,3-dihydro-2H-imidazol-2-ylidene]dichloro(4,5-dihydro-2-phenyloxazole-κN3)palladium, 95% |
C36H45Cl2N3OPd | |
| Z756498 | 1332478-75-7 | (Z)-2,6-二氟-4-((2-甲基-5-氧代恶唑-4(5H)-亚基)甲基)苯基 乙酸酯, 98% (Z)-2,6-Difluoro-4-((2-methyl-5-oxooxazol-4(5H)-ylidene)methyl)phenyl acetate, 98% |
C13H9F2NO4 | |
| R809832 | 149524-42-5 | (R)-3-(3-氟苯基)-5-羟甲基恶唑烷-2-酮, 98% (R)-3-(3-Fluorophenyl)-5-(hydroxymethyl)oxazolidin-2-one, 98% |
C10H10FNO3 | |
| R811802 | 95530-58-8 | (R)-4-异丙基-2-恶唑烷酮, 98% (R)-(+)-4-Isopropyl-2-oxazolidinone, 98% |
C6H11NO2 | |
| R815930 | 90319-52-1 | (R)-4-苯基-2-恶唑烷酮, 98% (R)-(-)-4-Phenyl-2-oxazolidinone, 98% |
C9H9NO2 | |
| S802064 | 23632-66-8 | (S)-(+)-3(苄氧羰基)-5-氧代-4-恶唑啉乙酸, 97% (S)-(+)-3-(Benzyloxycarbonyl)-5-oxo-4-oxazolidineacetic acid, 97% |
C13H13NO6 | |
| S800215 | 152305-23-2 | (S)-4-(4-氨基苄基)-1,3-噁唑烷-2-酮, 98% (S)-4-(4-Aminobenzyl)-2(1H)-oxazolidinone, 98% |
C10H12N2O2 |